Rikin Mehta v. Hirsh Singh

New Jersey Superior Court Appellate Division·Decided July 1, 2025·No. A-0409-23·Unpublished

Opinion

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION This opinion shall not "constitute precedent or be binding upon any court ." Although it is posted on the internet, this opinion is binding only on the parties in the case and its use in other cases is limited. R. 1:36-3.

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION

DOCKET NO. A-0409-23

RIKIN MEHTA and MEHTA FOR U.S. SENATE,

Plaintiffs-Appellants,

v.

HIRSH SINGH and SINGH FOR SENATE,

Defendants-Respondents.

Submitted April 30, 2025 – Decided July 1, 2025 Before Judges Currier, Marczyk, and Paganelli.

On appeal from the Superior Court of New Jersey, Law Division, Morris County, Docket No. L-0068-21.

Murray-Nolan Berutti LLC, attorneys for appellants (Ronald A. Berutti, on the briefs).

Hirsh Singh, respondent pro se.

PER CURIAM

The dispute between the parties arises out of a contentious political race in which the two candidates vied for the Republican nomination for New Jersey's United States Senate seat in 2020. Plaintiffs, Dr. Rikin Mehta (Mehta) and Mehta for U.S. Senate, instituted suit, alleging defendants engaged in a defamatory smear campaign against plaintiffs, including the publication of numerous allegedly false and defamatory press releases as well as the hiring of third parties to spread misinformation about plaintiffs.

Defendants moved for summary judgment. The trial court granted the motion, finding: (1) plaintiffs failed to show by clear and convincing evidence that defendants acted with actual malice in making their publications; and (2) defendants' actions were not defamatory as their publications constituted opinions and hyperbole rather than assertions of fact. We affirm.

I.

Mehta is an adjunct law professor as well as a co-founder and board member of two companies that operate in the medical resource and pharmaceutical fields. From 2008 to 2014, Mehta worked for the United States Food and Drug Administration in the compliance office. Mehta then worked for the District of Columbia Department of Health as a Senior Deputy Director. In

A-0409-23

2015, Mehta moved to New Jersey where he switched his voter registration from Democrat to Republican.

In March 2020, Mehta filed sixteen petitions containing a total of 1,117 signatures.1 After twelve of the signatures were rejected because the circulator of the petition was a registered Democrat, violating N.J.S.A. 19:23-11, Mehta filed more than 600 additional signatures. In April, a voter formally challenged Mehta's petitions to the Secretary of State of New Jersey, who then transmitted the matter to the Office of Administrative Law.

An Administrative Law Judge (ALJ) conducted a hearing. The petitioner-

voter asserted Mehta's name was listed in two slightly different formats, requiring the invalidation of some of the signatures. The ALJ concluded there was no evidence that the variation misled voters. The ALJ also found that even if all the challenges were successful, Mehta would still have had the required signatures to obtain the nomination. Therefore, the ALJ ordered that Mehta 's name be placed on the ballot. The ALJ's decision was adopted in its entirety by

1 To participate in a primary election at the time of these events, an individual had to submit 1,000 valid signatures from registered voters of the same party affiliation. N.J.S.A. 19:23-8. The statute was amended in 2025 and now requires 2,500 votes.

A-0409-23

the Secretary of State. Mehta won the Republican nomination and lost in the general election in November 2020 to Democrat Cory Booker.

A.

Plaintiffs filed their initial complaint in January 2021, alleging claims of false light, defamation, and defamation per se. These claims arose out of the following publications (and others): (1) A Shore News Network (Shore) headline from October 30, 2019, that stated "Obama Era Administrator, Big Pharma Rep Announces Run for U.S. Senate in New Jersey"; (2) a Shore headline from November 21, 2019, stating "Stuart Meissner and Rik Mehta, both running for Senate are newly minted Republicans with deep ties to the Democrat party"; (3) Shore headlines from February 2, 2020, stating "if elected, . . . Mehta, who is challenging Booker says he will protect the opioid supply chain for the pharmaceutical industry," and "pharmaceutical executive . . . Mehta who has come under fire this week for his support of the pharmaceutical industry and easier access to opioid-based prescription drugs"; (4) a Shore headline from February 4, 2020, stating "Somerset County Republicans joined the Union County Republicans in backing pharmaceutical executive [Mehta] who has come under fire this week for his support of the pharmaceutical industry and easier access to opioid-based prescription drugs"; (5) Shore headlines from

A-0409-23

February 10, 2020, stating "Mehta, [who] worked for opioid producing giant Pfizer and most recently worked for a company that sells Narcan has come under fire in recent weeks over a video that surfaced where he [stated] . . . '[w]e must protect America's opioid supply chain,'" "[Mehta] says we should protect America's opioid supply chain," and "[t]he newly minted Republican with deep campaign pockets and deep ties to the opioid epidemic plaguing New Jersey"; (6) a Shore headline from March 6, 2020, stating "[d]ays earlier, the group, led by its panel of leadership insiders on the screening committee unanimously endorsed . . . Obama era Democrat . . . Mehta for Senate to fulfill their obligation to North Jersey Republicans controlling this year's election statewide"; (7) a Shore headline from April 7, 2020 that stated "Swamp News: Mehta Turns on His Own Democrats; Criticizes Booker, Menendez"; (8) a Singh for Senate release titled "Democrat Judge allows [Mehta] to stay on ballot"; (9) a Shore headline from April 9, 2020 that stated "How Alleged Voter Fraud Almost Kept Former Democrat . . . Mehta Off 2020 Primary Election Ballot" as well as accompanying text from the article quoting Singh stating that Mehta relied on "the voting base of the Democrat Party and Green Party machinery to get on to the ballot prov[ing] . . . he is a pawn of the progressive establishment"; (10) a Singh for Senate release and a Shore headline from April 16, 2020 stating:

A-0409-23

"Mehta's 'N-Word' Problem" with an accompanying photograph of Mehta next to an individual wearing blackface; (11) a Shore headline from May 2, 2020 stating "Hirsh Singh Says Opponent, Former Democrat . . . Mehta Could Endorse Biden, Not Trump if His Ex-Boss is Tapped as Biden VP"; (12) a social media post, dated May 16, 2020, that stated "U[.]S[.] Senate candidate . . . Mehta wants to mandate COVID-19 vaccine to make his other pharmaceutical Democratic opiate peddlers rich!"; (13) press releases by Singh for Senate dated May 26, 2020, accusing Mehta of involvement with prescription drugs related to birth control and stating that Mehta is not pro-life; (14) a May 29, 2020 press release from Singh for Senate describing Mehta as a "Trojan Horse to keep Corey Booker in power"; (15) a statement made by Singh on June 29, 2020, describing Mehta as "a Democrat plant"; (16) a July 1, 2020, Singh for Senate press release accusing Mehta of being a lifelong Democrat; and (17) other press releases and statements by Singh made after the 2020 general election accusing Mehta of voter fraud as well as various other statements by news outlet pundits and social media posts. 2

2 The press releases and statements have similar themes as those already noted: characterizing Mehta as a Democrat plant who benefitted from voter fraud, has ties to pharmaceutical companies, is pro-opioids and pro-abortion, was embroiled in a racism scandal, and exposed citizens to COVID-19 by failing to quarantine after being exposed to the virus.

A-0409-23

B.

Free access — add to your briefcase to read the full text and ask questions with AI

Rikin Mehta v. Hirsh Singh, (N.J. Ct. App. 2025).

Rikin Mehta v. Hirsh Singh (Rikin Mehta v. Hirsh Singh) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

New York Times Co. v. Sullivan
376 U.S. 254 (Supreme Court, 1964)
Curtis Publishing Co. v. Butts
388 U.S. 130 (Supreme Court, 1967)
Harte-Hanks Communications, Inc. v. Connaughton
491 U.S. 657 (Supreme Court, 1989)
Milkovich v. Lorain Journal Co.
497 U.S. 1 (Supreme Court, 1990)
DeAngelis v. Hill
847 A.2d 1261 (Supreme Court of New Jersey, 2004)
Lynch v. New Jersey Education Ass'n
735 A.2d 1129 (Supreme Court of New Jersey, 1999)
Romaine v. Kallinger
537 A.2d 284 (Supreme Court of New Jersey, 1988)
Printing Mart-Morristown v. Sharp Electronics Corp.
563 A.2d 31 (Supreme Court of New Jersey, 1989)
McLaughlin v. Rosanio, Bailets & Talamo, Inc.
751 A.2d 1066 (New Jersey Superior Court App Division, 2000)
Ward v. Zelikovsky
643 A.2d 972 (Supreme Court of New Jersey, 1994)
Velantzas v. Colgate-Palmolive Co.
536 A.2d 237 (Supreme Court of New Jersey, 1988)
Lawrence v. Bauer Publishing & Printing Ltd.
446 A.2d 469 (Supreme Court of New Jersey, 1982)
Brill v. Guardian Life Insurance Co. of America
666 A.2d 146 (Supreme Court of New Jersey, 1995)
Globe Motor Company v. Ilya Igdalev(074996)
139 A.3d 57 (Supreme Court of New Jersey, 2016)
Dimitrakopoulos v. Borrus, Goldin, Foley, Vignuolo, Hyman & Stahl, P.C.
203 A.3d 133 (Supreme Court of New Jersey, 2019)